Home » ThromboGenics, BioInvent Get 5 Mln Euros From Roche
ThromboGenics, BioInvent Get 5 Mln Euros From Roche
Belgian biotech company ThromboGenics said it had received a payment of 5 million euros ($6.48 million) from Swiss drugmaker Roche for progress in developing anti-cancer drug TB-403.
Yahoo! Finance UK & Ireland
Yahoo! Finance UK & Ireland
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May